Evaluation of cardiovascular biomarkers in a randomized trial of fosamprenavir/ritonavir vs. efavirenz with abacavir/lamivudine in underrepresented, antiretroviral-naïve, HIV-infected patients (SUPPORT): 96-week results

BACKGROUND: Rates of cardiovascular disease are higher among HIV-infected patients as a result of the complex interplay between traditional risk factors, HIV-related inflammatory and immunologic changes, and effects of antiretroviral therapy (ART). This study prospectively evaluated changes in cardi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Princy, DeJesus, Edwin, Huhn, Gregory, Sloan, Louis, Small, Catherine Butkus, Edelstein, Howard, Felizarta, Franco, Hao, Ritche, Ross, Lisa, Stancil, Britt, Pappa, Keith, Ha, Belinda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685599/
https://www.ncbi.nlm.nih.gov/pubmed/23741991
http://dx.doi.org/10.1186/1471-2334-13-269

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3685599/
https://www.ncbi.nlm.nih.gov/pubmed/23741991
http://dx.doi.org/10.1186/1471-2334-13-269

Ejemplares similares